Functional characterization of CD34(+) cells from cryopreserved apheresis of patients with bone marrow-infiltrating malignancies (2022) Wendland K, Petkovic S, Aigner M, Strobel J, Müller F Conference contribution AMBORA Study/AMTS Competence and Advice Center for oral Tumor Therapy (2022) Schlichtig K Conference contribution Foreword of the DGHO Executive Board Vorwort des DGHO-Vorstandes (2022) Einsele H, Hochhaus A, De Wit M, Schulz CO Journal article Clinical trials in hematology and oncology Klinische Studien in der Hämatologie und Onkologie (2022) Einsele H, Steutel H, Eichhorst B, Gobeler ME, Hochhaus A, Nickel L, Von Messling V, et al. Journal article Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial (2022) Goerling U, Gauler T, Dietz A, Grünwald V, Knipping S, Guntinas-Lichius O, Frickhofen N, et al. Journal article A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study) (2022) Grünwald V, Hilser T, Meiler J, Goebell P, Ivanyi P, Strauss A, Hartmann A, et al. Journal article Response to treatment of uncommon EGFR mutations - a retrospective analysis from the German National Network Genomic Medicine Lung Cancer (nNGM) (2021) Janning M, Sueptitz J, Forstreuter A, Albers-Leischner C, Tufman A, Velthaus-Rusik JL, Reck M, et al. Conference contribution An ongoing, randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) (2021) Ahrens M, Escudier B, Haanen JBAG, Boleti E, Goupil GM, Grimm MO, Negrier S, et al. Conference contribution Health-related quality of life (HRQoL) in CML-patients at diagnosis compared to general population (2021) Lorch M, Pfirrmann M, Fabisch C, Oberle L, Kohn D, Kohlbrenner K, Bruemmendorf TH, et al. Conference contribution A pre-infection laboratory score identifies cancer patients at risk for severe COVID-19: an analysis of the ADHOK coronavirus tumor registry (2021) Roesch R, Suedhoff T, Wendtner CM, Kullmann F, Schaich M, Kubin T, Mueller-Naendrup C, et al. Conference contribution